SCHEMBL4285753

SCHEMBL4285753

CC1(C)CC[C@]2(C)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C(O)CCC(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 2/20 0.71
ALOX5 P09917 4/20 0.66
PTPN1 P18031 7/20 0.64
ALOX15 P16050 1/20 0.64
CES1 P23141 4/20 0.57
CES2 O00748 2/20 0.57
AKR1B10 O60218 3/20 0.54
AKR1B1 P15121 1/20 0.54
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54
PTPN2 P17706 4/20 0.53
POLB P06746 3/20 0.53
PSMB11 A5LHX3 2/20 0.53
PSMA7 O14818 2/20 0.53
PLA2G1B P04054 2/20 0.53
PTPRC P08575 2/20 0.53
PTPRF P10586 2/20 0.53
F3 P13726 2/20 0.53
PSMB1 P20618 2/20 0.53
ACP1 P24666 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4899244 0.87 PTPN1 (0.72) USP2ALOX5PTPN1CES1AKR1B10
SCHEMBL9565816 0.86 ALOX5 (0.61) USP2ALOX5PTPN1ALOX15CES1
SCHEMBL4735932 0.85 PTPN1 (0.61) USP2ALOX5PTPN1ALOX15CES1
Beta-Amyrin SCHEMBL1696463 0.83 USP2 (1.00) USP2ALOX5PTPN1ALOX15CES1
Beta-Amyrin SCHEMBL12313094 0.83 USP2 (1.00) USP2ALOX5PTPN1ALOX15CES1
Beta-Amyrin SCHEMBL18687837 0.83 USP2 (1.00) USP2ALOX5PTPN1ALOX15CES1
Beta-Amyrin SCHEMBL3119711 0.83 USP2 (1.00) USP2ALOX5PTPN1ALOX15CES1
Beta-Amyrin SCHEMBL14828378 0.83 USP2 (1.00) USP2ALOX5PTPN1ALOX15CES1
Beta-Amyrin SCHEMBL14226156 0.83 USP2 (1.00) USP2ALOX5PTPN1ALOX15CES1
Beta-Amyrin SCHEMBL377754 0.83 USP2 (1.00) USP2ALOX5PTPN1ALOX15CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7618946-B2 Analgesic compounds, extracts containing same and methods of preparation GRIFFITH UNIVERSITY (AU) 2009-11-17 US disclosed
US-20070270375-A1 Novel Analgesic Compounds, Extracts Containing Same and Methods of Preparation JARLMADANGAH BURU ABORIGINAL CORPORATION (AU) 2007-11-22 US disclosed
EP-1687320-A1 NOVEL ANALGESIC COMPOUNDS, EXTRACTS CONTAINING SAME AND METHODS OF PREPARATION GRIFFITH UNIVERSITY (AU) 2006-08-09 EP disclosed
WO-2005051969-A1 NOVEL ANALGESIC COMPOUNDS, EXTRACTS CONTAINING SAME AND METHODS OF PREPARATION GRIFFITH UNIVERSITY (AU) 2005-06-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070270375-A1 Novel Analgesic Compounds, Extracts Containing Same and Methods of Preparation DDOST, BBOX1, DAD1 USP2 1794/4885ALOX5 562/4885PTPN1 4182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.